ImmuCell

$5.82
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.23 (+4.10%) Today
-$0.02 (-0.34%) As of 11:00 PM UTC after-hours

Why Robinhood?

You can buy or sell ImmuCell and other stocks, options, and ETFs commission-free!

About ICCC

ImmuCell Corp. engages in the development, acquisition, manufacture and sale of products that improve the health and productivity of cows for the dairy and beef industries. Its products include first defense for scours, California mastitis test kit and purified nisin intramammary treatment for mastitis. The company was founded in 1982 and is headquartered in Portland, ME. The listed name for ICCC is ImmuCell Corporation Common Stock.

CEO
Michael F. Brigham
Employees
54
Headquarters
Portland, Maine
Founded
1982
Market Cap
42.12M
Price-Earnings Ratio
Dividend Yield
Average Volume
4.95K
High Today
$5.84
Low Today
$5.64
Open Price
$5.65
Volume
2.35K
52 Week High
$8.13
52 Week Low
$3.70

Collections

ICCC Earnings

-$0.11
-$0.06
-$0.02
$0.03
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Estimated
-$0.08 per share
Actual
-$0.04 per share

You May Also Like